[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:accelerated-phase-myeloproliferative-neoplasm":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Accelerated Phase Myeloproliferative Neoplasm",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07148947","Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms",[11],"Phase 2","RECRUITING","2026-08-26T02:17:04.346841Z","2026-05-05T02:43:28.314062Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06661915","A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)",[11],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:28.360451Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT07362225","MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)",[],"2026-08-26T02:15:36.077529Z","2026-05-13T02:55:06.699757Z",[],[]]